Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss)/income	$ (313,627)	$ 2,049,676
Adjustments to reconcile net (loss)/income to net cash provided by/ (used in) operating activities:
Depreciation and amortization expense	1,441	195,709
Stock compensation expense	236,455	562,330
Amortization of marketing costs settled with common stock	50,000
Amortization of deferred origination fees		(27,970)
Provision (benefit) for credit losses		(68,787)
Income tax benefit		(438,885)
Change in the fair value of deferred consideration	(161,000)	(184,535)
Change in fair value of warrant	(1,116,082)	(1,255,487)
Changes in operating assets and liabilities:
Right-to-use asset (net)	(892)	9,552
Accounts receivable – trade	43,813	(31,333)
Accounts receivable – related party	333,947	983,930
Prepaid expenses	101,005	77,303
Accrued interest receivable	13,418	(3,111)
Other current assets		82,657
Other current liabilities	17,016	10,048
Accounts payable	126,924	(38,153)
Accounts payable – related party	82,220	(451,622)
Accrued expenses	(535,902)	(363,347)
Contract liabilities	(19,230)	(19,230)
Net deferred indemnified loan origination fees		386,602
Security deposit	(236)	(224)
Net cash provided by (used in) operating activities	(1,140,730)	1,475,123
CASH FLOWS PROVIDED BY INVESTING ACTIVITIES:
Net proceeds from loan repayment	3,245	3,014
Net cash provided by investing activities	3,245	3,014
CASH FLOWS USED IN FINANCING ACTIVITIES:
Repayment of senior secured promissory note	(255,765)	(740,544)
Net cash used in financing activities	(255,765)	(740,544)
Net (decrease)/increase in cash and cash equivalents	(1,393,250)	737,593
Cash and cash equivalents – beginning of period	2,324,647	4,888,769
Cash and cash equivalents – end of period	931,397	5,626,362
Supplemental disclosure of cash flow information
Interest paid	113,561	156,414
Reclassification of forward purchase receivable	$ 4,584,221